Hello, Fool! | Login | Signup | My Fool
Oct 12, 2008 7:18 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.
View All Commentary (AMLN)
Recs
bill51347 (90.45) Submitted: 11/26/07 5:53 PM : Start Price: $38.80 AMLN Score: 30.74
Great products, poor management.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK